RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 51,192 followers.

RT @FrontImmunol: New Research: RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequenc…

26 Jan 2023

Reply Repost Favourite

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis https://t.co/d5IufqX16O https://t.co/zKOQcHXSfW

26 Jan 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequenc…

26 Jan 2023

Reply Repost Favourite

New Research: RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis: Background Glioma is one of the most common, primary, and lethal adult brain tumors because of its extreme… https://t.co

26 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.